Craig Horbinski

About Craig Horbinski

Craig Horbinski, With an exceptional h-index of 72 and a recent h-index of 56 (since 2020), a distinguished researcher at North Western University, specializes in the field of neuropathology, brain tumors, pathology, glioma, meningioma.

His recent articles reflect a diverse array of research interests and contributions to the field:

The immune system and metabolic products in epilepsy and glioma-associated epilepsy: emerging therapeutic directions

Predictors of salvage therapy for parasagittal meningiomas treated with primary surgery, radiosurgery, or surgery plus adjuvant radiotherapy

The Evolving Classification of Meningiomas: Integration of Molecular Discoveries to Inform Patient Care

494 Evaluating ERK1 2 Phosphorylation as a Predictive Biomarker for Survival in Recurrent Glioblastoma Patients: A REMARK Criteria-guided Analysis of a Clinical Trial Cohort …

Characterization of Immune Cell Heterogeneity, Key B Cell Subtypes, and Macrophages Functions Using Multiplex Immunofluorescence and Single-cell RNA Sequencing in Chordomas

Blood-Brain Barrier Opening with Ultrasound Augments Doxorubicin and Anti-PD-1 Therapy Efficacy, Intracranial Immune Activation, and Prolongs Survival in Preclinical Glioma Models

1228 Comprehensive T-cell Profiling in Chordomas: Single-cell RNA-Seq and TCR Profiling Analysis Uncover Antitumor and Exhaustion Phenotypes for Targeted Immunotherapies

Lactate dehydrogenase A regulates tumor-macrophage symbiosis to promote glioblastoma progression

Craig Horbinski Information

University

Position

___

Citations(all)

17556

Citations(since 2020)

12595

Cited By

9001

hIndex(all)

72

hIndex(since 2020)

56

i10Index(all)

156

i10Index(since 2020)

141

Email

University Profile Page

Google Scholar

Craig Horbinski Skills & Research Interests

neuropathology

brain tumors

pathology

glioma

meningioma

Top articles of Craig Horbinski

The immune system and metabolic products in epilepsy and glioma-associated epilepsy: emerging therapeutic directions

2024/1/1

Predictors of salvage therapy for parasagittal meningiomas treated with primary surgery, radiosurgery, or surgery plus adjuvant radiotherapy

Journal of Clinical Neuroscience

2024/6/1

The Evolving Classification of Meningiomas: Integration of Molecular Discoveries to Inform Patient Care

2024/4/30

494 Evaluating ERK1 2 Phosphorylation as a Predictive Biomarker for Survival in Recurrent Glioblastoma Patients: A REMARK Criteria-guided Analysis of a Clinical Trial Cohort …

Neurosurgery

2024/4/1

Li Chen
Li Chen

H-Index: 44

Craig Horbinski
Craig Horbinski

H-Index: 43

Hui Zhang
Hui Zhang

H-Index: 16

Characterization of Immune Cell Heterogeneity, Key B Cell Subtypes, and Macrophages Functions Using Multiplex Immunofluorescence and Single-cell RNA Sequencing in Chordomas

Neurosurgery

2024/4/1

Blood-Brain Barrier Opening with Ultrasound Augments Doxorubicin and Anti-PD-1 Therapy Efficacy, Intracranial Immune Activation, and Prolongs Survival in Preclinical Glioma Models

Neurosurgery

2024/4/1

1228 Comprehensive T-cell Profiling in Chordomas: Single-cell RNA-Seq and TCR Profiling Analysis Uncover Antitumor and Exhaustion Phenotypes for Targeted Immunotherapies

Neurosurgery

2024/4/1

Lactate dehydrogenase A regulates tumor-macrophage symbiosis to promote glioblastoma progression

Nature communications

2024/3/5

Cancer-associated fibroblast–secreted collagen is associated with immune inhibitor receptor LAIR1 in gliomas

Journal of Clinical Investigation

2024/2/15

ERK1/2 Phosphorylation Predicts Survival in Recurrent Glioblastoma Following Intracerebral and Adjuvant PD-1/CTLA-4 Immunotherapy: A REMARK-guided Analysis

Clinical Cancer Research

2024/1/17

Age-related loss of Notch3 underlies brain vascular contractility deficiencies, glymphatic dysfunction, and neurodegeneration in mice

The Journal of clinical investigation

2024/1/16

Prohibitin Expression in Antigen-Presenting Cells: Implications for Inciting Trigger in CNS IgG4-Related Disease

Annals of case reports

2024

Isocitrate dehydrogenase (IDH) mutant gliomas: a Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions

2023/1/1

The MIF promoter SNP rs755622 is associated with immune activation in glioblastoma

JCI insight

2023/7/7

A novel BRAF:: PTPRN2 fusion in meningioma: a case report

Acta Neuropathologica Communications

2023/12/8

Postoperative risk of IDH-mutant glioma–associated seizures and their potential management with IDH-mutant inhibitors

The Journal of clinical investigation

2023/6/15

Glioma Response to IDH Inhibition: Real-World Experience

Clinical Cancer Research

2023/12/1

Craig Horbinski
Craig Horbinski

H-Index: 43

Advanced age in humans and mouse models of glioblastoma show decreased survival from extratumoral influence

Clinical Cancer Research

2023/12/1

NCCN CNS tumor guidelines update for 2023

2023/12/1

Craig Horbinski
Craig Horbinski

H-Index: 43

See List of Professors in Craig Horbinski University(North Western University)

Co-Authors

academic-engine